iHuman
6 hedge funds and large institutions have $199K invested in iHuman in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.02% more ownership
Funds ownership: 0.08% → 0.1% (+0.02%)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
9% less capital invested
Capital invested by funds: $219K → $199K (-$20.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$39.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$16.6K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$6.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$25.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.17K |
IH Hedge Fund Activity: Q4 2024 in Review
6 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q4 2024, worth a combined $199K — down 9.3% from $219K a quarter earlier.
Fund positioning in IH was balanced in Q4 2024: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $39.1K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $25.6K sold.
- 6 institutional investors held iHuman (IH) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $199K of iHuman stock for Q4 2024, down 9.3% quarter-over-quarter.
- 1 fund opened new iHuman positions in Q4 2024 and 1 closed out, a net change of 0 holders.
- The largest iHuman buyer in Q4 2024 was Morgan Stanley, an estimated $39.1K added.
- The largest iHuman seller in Q4 2024 was Two Sigma Securities, an estimated $25.6K sold.
Based on aggregated 13F filings for Q4 2024.